Back to Neurology
Neurologyv2000Evidence-Based

Alberta Stroke Program Early CT Score (ASPECTS)

Quantifies early ischemic changes in MCA territory on non-contrast CT to predict stroke outcome and guide treatment decisions

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
aspects score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Alberta Stroke Program Early CT Score (ASPECTS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Start with 10 points. Subtract 1 point for each region with focal edema or parenchymal hypoattenuation: Caudate, Lentiform, Internal Capsule, Insular ribbon, M1, M2, M3, M4, M5, M6

Clinical Pearls & Practice Notes

  • ASPECTS score ranges from 0-10 points (10 = normal, 0 = extensive infarction)
  • Evaluated on two standardized axial CT cuts: basal ganglia level and supraganglionic level
  • Subtract 1 point for each region with ≥1/3 area involvement
  • Score ≤7 predicts poor functional outcome and increased hemorrhage risk
  • Score ≥8 indicates good candidates for IV thrombolysis
  • Score ≥6 may be considered for mechanical thrombectomy
  • Correlates inversely with NIHSS score and stroke severity
  • Predicts 3-month functional outcome and symptomatic ICH risk
  • Used in major stroke trials (ESCAPE, SWIFT-PRIME) for patient selection
  • Requires assessment of all axial cuts, not just two standardized levels
  • Should be used with clinical assessment and other imaging findings
  • Interrater reliability is good with proper training

Evidence & Literature Citations

  1. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355(9216):1670-4.
  2. Pexman JH, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001;22(8):1534-42.
  3. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-30.

Score Interpretation Ranges

Extensive Infarction0 – 4 pts

Extensive MCA territory involvement

Large Infarction5 – 7 pts

Large MCA territory involvement

Favorable8 – 10 pts

Limited MCA territory involvement

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.